Innovative business development in the Lithuanian capital
Vilnius City Innovation Industrial Park is the first and only industrial park in the capital of Lithuania, dedicated exclusively to the development of innovative business.
24 ha VCIIP territory is surrounded by national forests and already has a fully developed infrastructure. It is dedicated to Lithuanian and foreign companies that want to build research centres, laboratories or factories, as well as to business and science collaboration; nearby are some of the best universities in Lithuania, as well as main science centres.
In 2015, VCIIP was granted the status of a national importance economic project.
The obvious reasons to apply
Strategical location and great access
VCIIP is situated in Vilnius city, 30 minutes from the old town, the railway and bus stations, and the international airport. Three public transport stops – „Inovacijų pramonės parkas”, „Miškadvario” and „Vismaliukai” – are located in VCIIP. Although city life is really close by, the area is conveniently situated away from the street noise, surrounded by national forests.
The industrial park already has a developed infrastructure, from engineering networks to communications. All you have to do is apply and settle down.
Partnership oriented community
VCIIP was created exclusively for innovative companies that are operating in the seven areas of smart specialisation. It encourages partnership and clustering between its customers in order to take full advantage of the VCIIP community’s benefits.
The merge of science and business
VCIIP is part of the Integrated Science, Studies and Business Valley “Sauletekis” program. Nearby are two of the best Lithuanian universities and their campuses, three science centres, two science and technology parks, as well as excellent conditions for R&D infrastructure development and human resource management.
From startup to investor
VCIIP is open to companies of all sizes: from successful global companies to start-ups.
Status of national importance. No infrastructure charge
In 2015 VCIIP was granted the status of economic project of national importance that is strengthening the Lithuanian innovation system. Therefore, infrastructure development charge is not applied to the investors establishing at VCIIP.
VCIIP has been in operation since August, 2018.
Already reached results
New job openings
Technology Development Centre
By the 2025 III quarter, a specialized Technology Development Center will be built at VCIIP, offering unique laboratory facilities specialized for the life sciences.
It is expected that life sciences companies will be located in the premises of the Technology Development Center, also – open access centers will operate here, the infrastructure and services of which will be available not only to VCIIP TDC residents, but also to other innovative companies.
Life Sciences Digital Innovation Hub (LS DIH Lithuania) Cluster is a platform for business-research partnership, dedicated to fostering digital innovation in the life sciences, bringing together research, business and public sector institutions and organizations.
Industrial Park Plan
- Subleased lands
- Operator of VCIIP
- VCIIP operator‘s Science and Business Incubator (until the end of 2022)
- Land for long-term sublease
- State forest / Public areas
- Planned streets
- Forests / Residential areas
- Reserved lands
Customers and partners’ comments
“The biopharmaceutical market is a dynamic and rapidly developing field, where several important trends are observed: the growth of biological therapy and genetic engineering, personalised medicine, innovations in bioprocess technologies, etc. All these innovations require high bioprocess flexibility, precision, and high-class risk management – all of which we can offer in the development and supply of single-use products. And VCIIP was selected because of a focus on innovative industry development. This reflects our mission to support innovative biotech industry companies, allows us to be in an innovative environment and seek valuable collaborations with companies based at VCIIP.”
“Currently, the main sweetener in the world is traditional sugar, but its popularity in the world has been declining for 10 years in a row. The main reasons for this are the trends of healthy lifestyle and well-being, the intervention of governments in the form of taxes and the recommendations of global organisations such as WHO, CDC, OHID to limit the consumption of sweeteners (including sugar). We see that the place of ordinary sweeteners is little by little being taken by artificial sweeteners of high intensity without calories. Here at VCIIP “Pentasweet” will develop a natural (not artificial) sweetener that will be able to compete with both ordinary sweeteners and artificial ones, while maintaining the best qualities of being sweet, being virtually calorie free and inexpensive. And we chose VCIIP because of the location, availability of resources, convenience, logistics and land lease terms.”
„The world is undergoing rapid developments, technological changes and an increasing pace of life. People encounter much stress and tension, which affect their emotional environment and physical condition. A healthy diet, which nowadays is hardly imagined without food supplements, is one of the major means to stay healthy and active. So racing to satisfy the daily needs of a modern human being, we keep studying the composition of contemporary food supplements and their functional elements to offer innovative solutions. That’s why we are planning to built a modern research laboratory and food supplement plant in the VCIIP territory, that will allow us to expand the range of provided products and services.”
„Most life sciences companies face similar challenges as they grow: first and foremost, the R&D and production infrastructure meeting GMP and GLP standards. In recent years, “CMB medicina” together with partners, have been carrying out R&D and production activities in the field of health technologies and biotechnologies quite intensively, therefore the need for infrastructure capacity has increased, and the possibility of concentrating activities in one place in Vilnius seemed appropriate. Therefore, in order to make better use of networking and synergy opportunities for faster development of “CMB medicina” and other companies in the sector, we chose VCIIP.”
„We have never had any doubts about the development of “CMB medicina” in Vilnius. And the choice to plan the development at VCIIP was determined by several important factors: first of all – the developed transport infrastructure and possibility to establish relatively quickly, as well as the strong core of biotechnology companies already established at VCIIP and the neighbourhood of Vilnius University and Vilnius Tech. These are important conditions that, with the development of the company’s R&D and production infrastructure, will enable the growth of both the company and the cluster of advanced therapy medicinal products and other health technologies and biotechnologies research coordinated by “CMB medicina”.”
„To continue offering Lithuanian and foreign families a world-class education with the infrastructure that meets its needs, we have planned the development of our new campus in Vilnius City Innovation Industrial Park. We have chosen VCIIP not only because of its special location surrounded by nature, but also because of the strong scientific and business community that is emerging in the innovation industrial park, with which we expect strong synergies. We employ the latest technology to enhance children’s learning experience and therefore this is an extraordinary opportunity to integrate experiential education into the learning process and to give students a chance to observe closely how scientific discoveries and innovations are born.”
„The Stem Cell Research Centre has reached the point for development. We chose a place for it in Vilnius, because the largest biotechnology competencies in Lithuania are concentrated here. For us, Vilnius is a strategic place for development due to employees, logistics and interaction with other companies in our group. We chose Vilnius City Innovation Industrial Park because of the convenient territory for business development and important communications. In addition, a unique concentration of life sciences companies and research institutions is forming in this area, with which we expect high synergy. This will be a great place to work for our existing and new employees. We have already envisaged opportunities for further development of the company – we have left room for the second stage of the company’s development. When the company will need larger biotechnology production facilities, we hope to establish a 15,000 m2 biotechnology plant here in the future.”
„The ability to establish and adapt infrastructure to our needs comes rarely, especially in such a convenient location. We see the proximity of creative companies and research institutions in the park as an opportunity to strengthen business-business and science-business synergies, which will help to implement complex projects more efficiently. No less important reason – we believe in Vilnius as a city where the highest-level professionals would like to live and create, we believe in the vision and mission of the Park. Therefore, the decision to settle at VCIIP was very simple.”
“Our decision to settle at VCIIP is based on several reasons – it is a convenient location with developed infrastructure, rapidly growing VCIIP life sciences community, and of course – the value proposition itself, which allows us to plan the rapid development of the company. In preparation for the expansion of the production of immunological diagnostic tests and their components, we are going to set up a factory and laboratory to develop new products at VCIIP by the end of 2023. It’s an important move which will help us to grow the company’s scientific and innovative potential in the future.”
“The VCIIP management team is highly oriented to life sciences sector growth and has put significant effort into accommodating our requirements and helping us grow.”
“BioProcess Solutions” is establishing at VCIIP
Another biotechnology company – “BioProcess Solutions” is establishing at the Vilnius City Innovation Industrial Park. The company, which supplies single-use plastic products and systems designed specifically for the needs of the customer’s bioprocesses for biotechnology, biopharmaceutical, and pharmaceutical customers, plans to start operations as early as 2024. At VCIIP company will develop, design, and supply disposable products and systems dedicated to bioprocesses.
The construction of a specialized Life Sciences Technology Development Center is starting at the Vilnius City Innovation Industrial Park
The building will be adapted for scientific research and applied activities and most of the building’s area will be occupied by specialized life sciences laboratories, and office premises. “The Technology Development Center is a very important part of the ecosystem of the Vilnius City Innovation Industrial Park. It will allow VCIIP to attract sustainable companies operating in the field of life sciences and create physical conditions for the faster development of innovations and technologies developed by them”, says the CEO of Northtown Vilnius, operator of VCIIP Dr Gediminas Pauliukevičius.
Innovative food supplements company “Pentasweet” is establishing at VCIIP
Another biotechnology company – Pentasweet, carrying out research and experimental development activities in the fields of biotechnology and agro-innovation, is starting its establishment at the Vilnius City Innovation Industrial Park. The company developing innovative food products and supplements plans to establish at VCIIP by 2026. It is expected that the investment in Pentasweet’s R&D and production infrastructure, meeting the requirements of good production and laboratory practice, in the innovation park will reach 18 million Euros.
The British School of Vilnius opened their new campus in Vilnius City Innovation Industrial Park
This project is particularly important for our community at VCIIP. The demand for high-quality, internationally recognised educational services in Vilnius is growing, and the fact that the British School of Vilnius’ education model is oriented towards STEAM only reinforces the school’s connection to the VCIIP community. Soon, VCIIP will become a city within a city, where about 1000 people working in Lithuanian and international companies and research centres located here, will circulate daily.
BIO International Convention in Boston – Biotechnology Trends Worldwide and in Lithuania
VCIIP visited BIO International Convention in Boston with the Lithuanian delegation from June 5th to 8th, 2023. VCIIP has been participating in the world’s largest biotechnology exhibition for several years now, aiming not only to establish connections but also to develop VCIIP in line with global biotechnology trends and practices, and to gain experience on how to strengthen innovation and the biotechnology ecosystem in Lithuania.
The subsidiary company “World Courier Lithuania” of the global pharmaceutical corporation “Amerisource Bergen” is joining the LS DIH cluster
World Courier is a subsidiary of the global pharmaceutical corporation “Amerisource Bergen.” The group employs over 40000 employees working in 150 offices worldwide. The company has extensive experience in temperature-controlled shipments, handling both life sciences products and clinical trials.
Vilnius City Innovation Industrial Park is celebrating its 5th birthday
In April 2018, the municipality of Vilnius established Vilnius City Innovation Industrial Park and in August appointed Northtown Vilnius as its operator.
5 years after the establishment of the Park, the attracted investments already exceed 73 million euros, 20 companies and 6 clusters are located in the territory, more than 500 high added value generating new job openings have been created, and a business incubator established.
The Minister of Economy and Finance Aušrinė Armonaitė visited Vilnius City Innovation Industrial Park
The Minister of Economy and Finance Aušrinė Armonaitė and her team visited Vilnius City Innovation Industrial Park.
During the visit, the vision and development of the Vilnius City Innovation Industrial Park, the establishment of investors and their activities at VCIIP were discussed. Guests also visited “Poliprojektas” and observed tests in their new-generation automatic fire extinguishing systems research laboratory.
Northtown Vilnius has become a member of LithuaniaBIO
The operator of the Vilnius City Innovation Industrial Park (VCIIP) Northtown Vilnius has become a member of the association LithuaniaBIO.
LithuaniaBIO – the association of Lithuanian biotechnologists established in 2003, today uniting more than 40 companies and institutions operating in the field of life sciences and biotechnology. The association promotes biotechnology and its wider application in the Lithuanian economy in solving global challenges of environmental protection and quality of life.